Operating profit reached 179 million yen, while pretax profit mirrored the final net profit figure of 174 million yen. Shareholders saw earnings per share at 8.80 yen, with diluted earnings coming in at 8.77 yen. The company confirmed no dividend payments for the midyear period and indicated that future dividend distributions remain subject to official forecasts.
In section Market Quotes
CellSource Reports 174 Million Yen Net Profit for Nine-Month Period
CellSource Co. Ltd. posted a net profit of 174 million yen for the nine-month period ending July 31, 2026. The Japanese firm, listed under 4880.TO, recorded total revenue of 2.56 billion yen, according to financial results prepared in accordance with local accounting standards.
Comments (0)
No comments yet. Be the first!